Augmented α-adrenergic constriction of atherosclerotic human coronary arteries

Circulation

Volumn 99, Issue 16, 1999, Pages 2090-2097

  Baumgart, Dietrich ^a   Haude, Michael ^b   Görge, Günter ^b   Liu, Fengqi ^b   Ge, Junbo ^b   Große Eggebrecht, Claudia ^b   Erbel, Raimund ^b   Heusch, Gerd ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

Angiography; Coronary disease; Ultrasonics

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AZEPEXOLE; LACTIC ACID; METHOXAMINE;

ADULT; AGED; ALPHA ADRENERGIC STIMULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0033608950     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.16.2090     Document Type: Article

References (41)

1. Mohrman DE, Feigl EO. Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res. 1978;42:79-86.
2. Murray PA, Vatner SF. α-Adrenoceptor attenuation of coronary vascular response to severe exercise in the conscious dog. Circ Res. 1979;45:654-660.
3. Baumgart D, Ehring T, Kowallik P, Guth BD, Krajcar M, Heusch G. Impact of α-adrenergic coronary vasoconstriction on the transmural myocardial blood flow distribution during humoral and neuronal adrenergic activation. Circ Res. 1993;73:869-886.
4. Heusch G, Deussen A. The effects of cardiac sympathetic nerve stimulation on the perfusion of stenotic coronary arteries in the dog. Circ Res. 1983;53:8-15.
5. 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res. 1988;62:436-442.
6. 2-adrenergic receptors in mediation of coronary vasoconstriction in hypoperfused ischemic myocardium during exercise. Circ Res. 1989;65: 1688-1697.
7. Heusch G. α-Adrenergic mechanisms in myocardial ischemia. Circulation. 1990;81:1-13.
8. 2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation. 1993;87: 1264-1274.
9. Young MA, Vatner SF. Enhanced adrenergic constriction of iliac artery with removal of endothelium in conscious dogs. Am J Physiol. 1986;250: H892-H897.
10. Rosendorff C, Hoffman JIE, Verrier ED, Rouleau J, Boerboom LE. Cholesterol potentiates the coronary artery response to norepinephrine in anesthetized and conscious dogs. Circ Res. 1981;48:320-329.
11. Orlick AE, Ricci DR, Alderman EL, Stinson EB, Harrison DC. Effects of alpha adrenergic blockade upon coronary hemodynamics. J Clin Invest. 1978;62:459-467.
12. Hodgson JM, Cohen MD, Szentpetery S, Thames MD. Effects of regional α-and β-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans. Circulation. 1989;79:797-809.
13. Chilian WM, Boatwright RB, Shoji T, Griggs DM. Evidence against significant resting sympathetic coronary vasoconstrictor tone in the conscious dog. Circ Res. 1981;49:866-876.
14. 2-adrenoceptors in normal and atherosclerotic human coronary circulation. Circulation. 1992;86:1116-1124.
15. Brown BG, Lee AB, Bolson EL, Dodge HT. Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise. Circulation. 1984;70:18-24.
16. Gordon JB, Ganz P, Nabel EG, Fish RD, Zebede J, Mudge GH, Alexander RW, Selwyn AP. Arteriosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest. 1989; 83:1946-1952.
17. Bortone AS, Hess OM, Gaglione A, Suter T, Nonogi H, Grimm J, Krayenbuehl HP. Effect of intravenous propranolol on coronary vasomotion at rest and during dynamic exercise in patients with coronary artery disease. Circulation. 1990;81:1225-1235.
18. Mudge GH, Grossman W, Mills RM Jr, Lesch M, Braunwald E. Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med. 1976;295:1333-1337.
19. Chierchia S, Davies G, Berkenboom G, Crea F, Crean P, Maseri A. α-Adrenergic receptors and coronary spasm: an elusive link. Circulation. 1984;69:8-14.
20. Kern MJ, Horowitz JD, Ganz P, Gaspar J, Colucci WS, Lorell BH, Barry WH, Mudge GH. Attenuation of coronary vascular resistance by selective alpha1-adrenergic blockade in patients with coronary artery disease. J Am Coll Cardiol. 1985;5:840-846.
21. Nabel EG, Gantz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 1988;77:43-52.
22. Zeiher AM Drexler H, Wollschläger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989;14:1181-1190.
23. Kobinger W, Pichler L. Alphal-and alpha2-adrenoceptor subtypes: selectivity of various agonists and relative distribution of receptors as determined in rats. Eur J Pharmacol. 1981;73:313-321.
24. Kobinger W, Pichler L. Pharmacological characterization of BHT-933 (2-amino-6-ethyl-4,5,7,8-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the "clonidine-type." Naunyn Schmiedebergs Arch Pharmacol. 1977;300:39-46.
25. Reiber JH, Schiemanck LR, van der Zwet PMJ, Goedhart B, Koning G, Lammertsma M, Danse M, Gerbrands JJ, Schalij MJ, Bruschke AVG. State of the art in quantitative coronary arteriography in 1996. In: Reiber JH, van der Wall EE, eds. Cardiovascular Imaging. Dordrecht, Boston, London: Kluwer Academic Publishers: 1996:39-56.
26. Ge J, Erbel R, Gerber T, Görge G, Koch L, Haude M, Meyer J. Intravascular ultrasound imaging of angiographically normal coronary arteries: a prospective study in vivo. Br Heart J. 1994;71:572-578.
27. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. Norwalk, Conn: Appleton & Lange;1994:1-345.
28. Cohen RA, Zitnay KM, Weisbrod RM. Accumulation of 5-hydroxytryptamine leads to dysfunction of adrenergic nerves in canine coronary artery following intimal damage in vivo. Circ Res. 1987;61:829-833.
29. Zanzinger J, Czachurski J, Seller H. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ Res. 1994;75:1073-1077.
30. Harrison DC, Freiman PC, Armstrong ML, Marcus ML, Heistad DD. Alterations of vascular reactivity in atherosclerosis. Circ Res. 1987; 61(suppl II):II-74-II-80.
31. 2-adrenoceptors and endothelium-derived relaxing factor. Circ Res. 1992;71:188-192.
32. Corr PB, Shayman JA, Kipnis RJ. Increased alpha-adrenergic receptors in ischemic cat myocardium: a potential mediator of electrophysiological derangements. J Clin Invest. 1981;67:1232-1236.
33. Tiefenbacher C, DeFily DV, Chilian WM. α-Adrenergic coronary arteriolar vasoconstriction is mediated by myocyte-derived endothelin. Circulation. 1998;98:9-12.
34. Lorenzoni R, Rosen SD, Camici PG. Effect of alpha1-adrenoceptor blockade on resting and hyperemic myocardial blood flow in normal humans. Am J Physiol. 1996;271:H1302-H1306.
35. Gregorini L, Fajadet J, Robert G, Cassagneau B, Bernis M, Marco J. Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents. Circulation. 1994;90: 895-907.
36. Vatner DE, Pagani M, Manders WT, Pasipoularides AD. Alpha adrenergic vasoconstriction and nitroglycerin vasodilation of large coronary arteries in the conscious dog. J Clin Invest. 1980;65:5-14.
37. 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol. 1984;6:961-968.
38. Erbel R, Ge J, Bockisch A, Kearney P, Görge G, Haude M, Schümann D, Zamorano J, Rupprecht HJ, Meyer J. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. Eur Heart J. 1996;17:880-889.
39. Cooks TM, Angus JA. Endothelium-dependent relaxation of coronary arteries by noradrenalin and serotonin. Nature. 1983;305:627-629.
40. 2-adrenoceptors. Eur J Pharmacol. 1982;82:199-202.
41. Feigl EO. The paradox of adrenergic coronary vasoconstriction. Circulation. 1987;76:737-745.